|
Bermuda
|
98-1343578
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Suite 1, 3rd Floor
11-12 St. James’s Square
London
SW1Y 4LB
United Kingdom
|
Not Applicable
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
☐ |
Accelerated filer
|
☐ |
|
Non-accelerated filer
|
☒ |
Smaller reporting company
|
☒ |
|
Emerging growth company
|
☐ |
|
Title of Securities
to be Registered
|
Amount to be
Registered(1)
|
Proposed
Maximum
Offering Price
Per Share(3)
|
Proposed
Maximum
Aggregate
Offering Price(3)
|
Amount of
Registration
Fee
|
|
Common Shares, $0.000017727 par value per share
|
3,963,979(2)
|
$20.77
|
$82,331,843.83
|
$8,982.41
|
| Item 3. |
Incorporation of Documents by Reference.
|
| (a) |
The Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed on May 18, 2020;
|
| (b) |
The information specifically incorporated by reference into the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020 from the Registrant’s Proxy Statement on Schedule 14A, filed on July 24, 2020;
|
| (c) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020, filed on August 11, 2020;
|
| (d) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020, filed on November 12, 2020;
|
| (e) |
The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2020, filed on February 11, 2021;
|
| (f) |
The Registrant’s Current Reports on Form 8-K filed on May 8, 2020, August 5, 2020, September
17, 2020, December 18, 2020, December 28, 2020 and January 4, 2021; and
|
| (g) |
The description of the Registrant’s Common Shares contained in the Registrant’s Registration Statement on Form
8-A, filed with the Commission on October 24, 2016 (File No. 001-37929) under the Exchange Act, including any amendment or report filed for the purpose of updating such description, including Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed on May 18, 2020.
|
| Item 4. |
Description of Securities
|
| Item 5. |
Interests of Named Experts and Counsel
|
| Item 6. |
Indemnification of Directors and Officers
|
| Item 7. |
Exemption from Registration Claimed.
|
| Item 8. |
Exhibits.
|
|
Incorporated by Reference
|
||||||
|
Exhibit
Number
|
Description of Document
|
Schedule/Form
|
File No.
|
Exhibit
|
Filing Date
|
|
|
Certificate of Incorporation.
|
S-1
|
333-213891
|
3.1
|
09/30/2016
|
||
|
Memorandum of Association.
|
S-1
|
333-213891
|
3.2
|
09/30/2016
|
||
|
Fifth Amended and Restated Bye-Laws.
|
10-Q
|
001-37929
|
3.3
|
02/10/2020
|
||
|
Opinion of Conyers Dill & Pearman Limited as to Legality.
|
||||||
|
2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.5
|
10/20/2016
|
||
|
Forms of Option Grant Notice and Option Agreement under 2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.6
|
09/30/2016
|
||
|
Form of Amendment No.1 to the Stock Option Grant Notice and Option Agreement under 2016 Equity Incentive Plan, as amended.
|
10-Q
|
001-37929
|
10.1
|
11/12/2019
|
||
|
Form of Early Exercise Stock Purchase Agreement under 2016 Equity Incentive Plan, as amended.
|
S-1
|
333-213891
|
10.7
|
09/30/2016
|
||
|
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended.
|
10-K
|
001-37929
|
10.30
|
05/24/2019
|
||
|
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended (2019 Form).
|
10-Q
|
001-37929
|
10.2
|
11/12/2019
|
||
|
Form of Restricted Stock Award Agreement under 2016 Equity Incentive Plan, as amended.
|
10-K
|
001-37929
|
10.31
|
05/24/2019
|
||
|
Consent of Independent Registered Public Accounting Firm.
|
||||||
|
Consent of Conyers Dill & Pearman Limited (included in Exhibit 5.1).
|
||||||
|
Power of Attorney (included on the signature page to this Registration Statement).
|
||||||
| Item 9. |
Undertakings
|
| 1. |
The undersigned Registrant hereby undertakes:
|
|
MYOVANT SCIENCES LTD.
|
||
|
By:
|
/s/ Matthew Lang
|
|
|
Matthew Lang
|
||
|
General Counsel and Corporate Secretary
|
|
Signature
|
Title
|
Date
|
||
|
/s/ David Marek
|
Principal Executive Officer and Director
|
April 6, 2021
|
||
|
David Marek
|
||||
|
/s/ Frank Karbe
|
Principal Financial and Accounting Officer
|
April 6, 2021
|
||
|
Frank Karbe
|
||||
|
/s/ Myrtle Potter
|
Chairman and Director
|
April 6, 2021
|
||
|
Myrtle Potter
|
||||
|
/s/ Terrie Curran
|
Director
|
April 6, 2021
|
||
|
Terrie Curran
|
||||
|
/s/ Mark Guinan
|
Director
|
April 6, 2021
|
||
|
Mark Guinan
|
||||
|
/s/ Adele Gulfo
|
Director
|
April 6, 2021
|
||
|
Adele Gulfo
|
||||
|
/s/ Hiroshi Nomura
|
Director
|
April 6, 2021
|
||
|
Hiroshi Nomura
|
||||
|
/s/ Kathleen Sebelius
|
Director
|
April 6, 2021
|
||
|
Kathleen Sebelius
|